284 related articles for article (PubMed ID: 32096183)
21. LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3.
Liu C; Zhuo H; Ye MY; Huang GX; Fan M; Huang XZ
Kaohsiung J Med Sci; 2020 Sep; 36(9):682-691. PubMed ID: 32391974
[TBL] [Abstract][Full Text] [Related]
22. Circular RNA_0037128 aggravates high glucose-induced damage in HK-2 cells via regulation of microRNA-497-5p/nuclear factor of activated T cells 5 axis.
Feng T; Li W; Li T; Jiao W; Chen S
Bioengineered; 2021 Dec; 12(2):10959-10970. PubMed ID: 34753398
[TBL] [Abstract][Full Text] [Related]
23. MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3.
Wang L; Li H
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32309847
[TBL] [Abstract][Full Text] [Related]
24. Circ_0068087 Promotes High Glucose-Induced Human Renal Tubular Cell Injury through Regulating miR-106a-5p/ROCK2 Pathway.
Feng F; Yang J; Wang G; Huang P; Li Y; Zhou B
Nephron; 2023; 147(3-4):212-222. PubMed ID: 35871508
[TBL] [Abstract][Full Text] [Related]
25. miRNA-483-5p Targets HDCA4 to Regulate Renal Tubular Damage in Diabetic Nephropathy.
Liu L; Chen H; Yun J; Song L; Ma X; Luo S; Song Y
Horm Metab Res; 2021 Aug; 53(8):562-569. PubMed ID: 34126643
[TBL] [Abstract][Full Text] [Related]
26. MiR-30c-5p/ROCK2 axis regulates cell proliferation, apoptosis and EMT via the PI3K/AKT signaling pathway in HG-induced HK-2 cells.
Cui L; Yu M; Cui X
Open Life Sci; 2020; 15(1):959-970. PubMed ID: 33817282
[TBL] [Abstract][Full Text] [Related]
27. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
[TBL] [Abstract][Full Text] [Related]
28. Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease.
Xue M; Cheng Y; Han F; Chang Y; Yang Y; Li X; Chen L; Lu Y; Sun B; Chen L
Int J Biol Sci; 2018; 14(11):1545-1557. PubMed ID: 30263007
[TBL] [Abstract][Full Text] [Related]
29. hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy.
Bai S; Xiong X; Tang B; Ji T; Li X; Qu X; Li W
Oxid Med Cell Longev; 2021; 2021():8814163. PubMed ID: 34257820
[TBL] [Abstract][Full Text] [Related]
30. Long non-cording RNA XIST promoted cell proliferation and suppressed apoptosis by miR-423-5p/HMGA2 axis in diabetic nephropathy.
Chen H; Guo Y; Cheng X
Mol Cell Biochem; 2021 Dec; 476(12):4517-4528. PubMed ID: 34532814
[TBL] [Abstract][Full Text] [Related]
31. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
[TBL] [Abstract][Full Text] [Related]
32. miR-30e targets GLIPR-2 to modulate diabetic nephropathy:
Zhao D; Jia J; Shao H
J Mol Endocrinol; 2017 Aug; 59(2):181-190. PubMed ID: 28733476
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of plasmacytoma variant translocation 1 (PVT1) inhibits high glucose-induced proliferation and renal fibrosis in HRMCs by regulating miR-23b-3p/early growth response factor 1 (EGR1).
Yu D; Yang X; Zhu Y; Xu F; Zhang H; Qiu Z
Endocr J; 2021 May; 68(5):519-529. PubMed ID: 33408314
[TBL] [Abstract][Full Text] [Related]
34. Danhong injection represses diabetic retinopathy and nephropathy advancement in diabetic mice by upregulating microRNA-30d-5p and targeting JAK1.
Deng W; Huang D; Xie H; Wang L; Shen Q; Zeng R; Huang Y; Li J; Yang B
Bioengineered; 2022 Apr; 13(4):8187-8200. PubMed ID: 35297304
[TBL] [Abstract][Full Text] [Related]
35. Circ_0114428 promotes proliferation, fibrosis and EMT process of high glucose-induced glomerular mesangial cells through regulating the miR-185-5p/SMAD3 axis.
Li B; Sun G; Yu H; Meng J; Wei F
Autoimmunity; 2022 Nov; 55(7):462-472. PubMed ID: 35880624
[TBL] [Abstract][Full Text] [Related]
36. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway.
Zhang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
[TBL] [Abstract][Full Text] [Related]
38. Coptis inhibited epithelial-mesenchymal transition and fibrogenesis of diabetic nephropathy through lncRNA CLYBL-AS2-miR-204-5p-SNAI1 axis.
Cai S; Liu J; Ma Q; Bao Y; Chen J; Li Y
J Drug Target; 2020 Nov; 28(9):939-948. PubMed ID: 32310009
[TBL] [Abstract][Full Text] [Related]
39. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
[TBL] [Abstract][Full Text] [Related]
40. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
